| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Worcester Foundation for Experimental Biology, Shrewsbury, Massachusetts
2
-Methyl-17ß-hydroxy-5
-androstan-3-one significantly increased the survival time of rats bearing mammary fibro adenomas. The extent of survival was related to the hormone responsiveness of the tumor.
1 Supported by USPHS Contract SA-43-ph-4354 from the Cancer Chemotherapy National Service Center, National Cancer Institute, NIH, and by Grant No. T-285 from the American Cancer Society.
2 Present address: Institute of Hormone Biology, Syntex Research Center, Palo Alto, California.
Received 1/29/65.
Revised 7/29/65.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |